The Legal 500

Twitter Logo Youtube Circle Icon LinkedIn Icon

DLA Piper LLP (US)

4365 EXECUTIVE DRIVE, SUITE 1100, SAN DIEGO, CA 92121-2133, USA
Tel:
Work +1 858 677 1400
Fax:
Fax +1 858 677 1401
Web:
www.dlapiper.com

Lisa Haile

Tel:
Work +1 858 677 1456
Email:
Web:
www.dlapiper.com/en/us/people/h/haile-lisa-a/
DLA Piper LLP (US)

Work Department

Patent Prosecution and Strategic Patent Counseling; Emerging Growth and Venture Capital; Intellectual Property and Technology; Corporate; International Trade, Regulatory and Government Affairs; Litigation, Arbitration and Investigations; Patent Litigation; Technology Tranactions and Strategic Sourcing; Trademark and Copyright; Life Sciences; Healthcare; Education; Energy and Natural Resources; Retail

Position

Partner

Career

Dr. Lisa Haile concentrates on patent protection.

Dr. Haile has special technical experience in molecular biology, immunology, cell biology, regenerative medicine including ESCs, iPSCs, pSCs, diagnostics, therapeutics, theranostics, drug delivery systems, host-vector systems, high throughput screening and bioinformatics. She has particular experience with patentability, non-infringement and validity opinions; licensing strategies; FDA counseling; due diligence work in connection with venture capital, private and public financing; mergers and acquisitions in the life sciences industry; and strategic counseling for comprehensive life sciences patent portfolio management

Education

J.D., California Western School of Law; Ph.D, Georgetown University School of Medicine; B.A., Rollins College


United States: Industry focus

Healthcare: life sciences

Within: Healthcare: life sciences

Co-heads of DLA Piper LLP (US)'s practice, San Diego-based Lisa Haile and Matthew Holian in Boston, specialize in patentability and licensing strategies, and product liability and mass tort, respectively. Recent highlights include obtaining issuance of multiple patents for Aegis Therapeutics’ key product areas and assisting Pfizer and Bristol-Myers Squibb (BMS) with multidistrict and state court litigation concerning alleged defects of the clients’ blockbuster anticoagulant medication Eliquis. New York-based litigator Loren Brown has been acting for Medtronic and Covidien in product liability litigation related to complications allegedly caused by some of Covidien’s implantable hernia mesh products. San Diego’s Larry Nishnick and Austin’s Aaron Fountain are names to note for corporate investment and patent litigation respectively.

[back to top]


Back to index

Legal Developments by:
DLA Piper LLP (US)

  • Sentencing guidelines for corporate manslaughter

    In February 2010 the Sentencing Guidelines Council (the SGC) issued definitive guidelines to courts on imposing appropriate sentences for corporate manslaughter and health and safety offences causing death. The SGC states that fines imposed on companies found guilty of corporate manslaughter should not fall below £500,000, while fines in respect of health and safety offences that are a significant cause of death should be at least £100,000. Crucially, the SGC declined to provide for a fixed link between the imposed fine and the turnover or profitability of the offending company.

    - DLA Piper UK LLP

Legal Developments worldwide

Legal Developments and updates from the leading lawyers in each jurisdiction. To contribute, send an email request to